Abstract

Topical medications to lower intraocular pressure (IOP) are central to managing glaucoma. However, issues with adherence, damage to the ocular surface, and high costs often limit their effectiveness, especially in elderly patients. Sustained-release intracameral drug delivery systems have emerged as a potential alternative. This report discusses the successful application of iDose TR in a 77-year-old woman with mild-to-moderate open- angle glaucoma who faced significant ocular surface disease and treatment challenges due to topical therapy. After sequential bilateral implantation, the patient maintained stable IOP control, reduced her use of topical medications, and saw a significant improvement in her quality of life.

Keywords

iDose, glaucoma, eye drop, corneal transplantation